(S)-tetrahydrocolumbamine oxidase (methylenedioxy-bridge-forming)
RxNorm 386893
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 386893 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: (S)-tetrahydrocolumbamine oxidase (methylenedioxy-bridge-forming).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
(S)-canadine synthase
(Atom ID: 1600310)
FN
Full form of descriptor (FN):
(S)-canadine synthase (substance)
(Atom ID: 1600312)
SY
Synonym (SY):
(S)-tetrahydroberberine synthase
(Atom ID: 1600313)
SY